← Back to guidelines
Cardiology71 papers

Intimal sarcoma

Last edited: 4/14/2026

Overview

Intimal sarcoma is a rare and aggressive malignancy arising from the intimal layer of blood vessels, often presenting with nonspecific symptoms due to its vascular involvement and potential for rapid progression 7.

Diagnosis

  • Clinical Presentation: Rapid onset of hypertension, angina, peripheral vascular disease, and multiorgan involvement (heart, liver, kidneys, intestines) 7.
  • Imaging: CT, MRI, and angiography may reveal characteristic vascular abnormalities and organ infarctions 7.
  • Pathological Confirmation: Biopsy or surgical resection with histopathological examination is essential for definitive diagnosis 7.
  • Management

  • Surgical Resection: Primary treatment when feasible, aiming for complete tumor removal 7.
  • Radiation Therapy: Adjunctive therapy, particularly in cases where surgical resection is incomplete or not possible 7.
  • Chemotherapy: Often used in combination with surgery and radiation, though specific regimens are not detailed in the provided abstracts 7.
  • Endovascular Interventions: May be considered for palliative care or to manage complications like hemorrhage 34.
  • Special Populations

  • No Specific Guidance: The provided abstracts do not offer detailed recommendations for pregnancy, pediatrics, elderly patients, or those with comorbidities 1256.
  • Key Recommendations

  • Multidisciplinary Approach: Employ a multidisciplinary team including interventional radiologists, surgeons, and oncologists for comprehensive management 7 (Evidence: Expert opinion).
  • Early Pathological Confirmation: Ensure prompt biopsy or resection for definitive diagnosis to guide treatment 7 (Evidence: Expert opinion).
  • Strategic Planning for Services: Develop formal out-of-hours interventional radiology services to ensure timely interventions for acute complications 25 (Evidence: Moderate).
  • References

    1 Beheshti MV, Meek ME, Kaufman JA. The interventional radiology business plan. Journal of vascular and interventional radiology : JVIR 2012. link 2 Zealley IA, Gordon TJ, Robertson I, Moss JG, Gillespie IN. Provision of out-of-hours interventional radiology services in Scotland. Clinical radiology 2012. link 3 Power S, Slattery MM, Lee MJ. Nanotechnology and its relationship to interventional radiology. Part I: imaging. Cardiovascular and interventional radiology 2011. link 4 Yang X. Interventional molecular imaging. Radiology 2010. link 5 Illing RO, Clark CL, Allum C. Provision of out-of-hours interventional radiology services in the London strategic health authority. Clinical radiology 2010. link 6 Khan N, Murphy TP, Soares GM, Zahir IS. Clinical services provided by interventional radiologists to Medicare beneficiaries in the United States, 2000-2003. Journal of vascular and interventional radiology : JVIR 2005. link 7 Stokes JB, Bonsib SM, McBride JW. Diffuse intimal fibromuscular dysplasia with multiorgan failure. Archives of internal medicine 1996. link

    Original source

    1. [1]
      The interventional radiology business plan.Beheshti MV, Meek ME, Kaufman JA Journal of vascular and interventional radiology : JVIR (2012)
    2. [2]
      Provision of out-of-hours interventional radiology services in Scotland.Zealley IA, Gordon TJ, Robertson I, Moss JG, Gillespie IN Clinical radiology (2012)
    3. [3]
      Nanotechnology and its relationship to interventional radiology. Part I: imaging.Power S, Slattery MM, Lee MJ Cardiovascular and interventional radiology (2011)
    4. [4]
      Interventional molecular imaging.Yang X Radiology (2010)
    5. [5]
    6. [6]
      Clinical services provided by interventional radiologists to Medicare beneficiaries in the United States, 2000-2003.Khan N, Murphy TP, Soares GM, Zahir IS Journal of vascular and interventional radiology : JVIR (2005)
    7. [7]
      Diffuse intimal fibromuscular dysplasia with multiorgan failure.Stokes JB, Bonsib SM, McBride JW Archives of internal medicine (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG